• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

WFH Guidelines for the Management of Hemophilia, 3rd edition.

作者信息

Srivastava Alok, Santagostino Elena, Dougall Alison, Kitchen Steve, Sutherland Megan, Pipe Steven W, Carcao Manuel, Mahlangu Johnny, Ragni Margaret V, Windyga Jerzy, Llinás Adolfo, Goddard Nicholas J, Mohan Richa, Poonnoose Pradeep M, Feldman Brian M, Lewis Sandra Zelman, van den Berg H Marijke, Pierce Glenn F

机构信息

Department of Haematology, Christian Medical College, Vellore, India.

A. Bianchi Bonomi Hemophilia and Thrombosis Centre, IRCCS Cà Granda Foundation, Maggiore Hospital Policlinico, Milan, Italy, and Sobi, Basel, Switzerland.

出版信息

Haemophilia. 2020 Aug;26 Suppl 6:1-158. doi: 10.1111/hae.14046. Epub 2020 Aug 3.

DOI:10.1111/hae.14046
PMID:
32744769
Abstract
摘要

相似文献

1
WFH Guidelines for the Management of Hemophilia, 3rd edition.《血友病管理的居家指南》第三版
Haemophilia. 2020 Aug;26 Suppl 6:1-158. doi: 10.1111/hae.14046. Epub 2020 Aug 3.
2
WHO/WFH recommendations, June 1997. Hemophilia care in developing countries.世界卫生组织/世界血友病联盟建议，1997年6月。发展中国家的血友病护理。
Haemophilia. 1998;4 Suppl 2:64-6.
3
WFH--the cornerstone of global development: 45 years of progress.居家办公——全球发展的基石：45年的进步
Haemophilia. 2008 Jul;14 Suppl 3:1-9. doi: 10.1111/j.1365-2516.2008.01707.x.
4
The WFH Haemophilia Centre Twinning Programme: 10 years of growth, 1993-2003.居家办公血友病中心结对项目：1993年至2003年的十年发展历程
Haemophilia. 2003 May;9(3):240-4. doi: 10.1046/j.1365-2516.2003.00759.x.
5
Developing and maintaining of hemophilia programs in developing countries.在发展中国家开展和维持血友病防治项目。
Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:46.
6
The World Federation of Hemophilia: 40 years of improving haemophilia care worldwide.世界血友病联盟：40年来改善全球血友病护理状况。
Haemophilia. 2003 Nov;9(6):663-9. doi: 10.1046/j.1351-8216.2003.00831.x.
7
World Federation of Haemophilia programs in developing countries.世界血友病联盟在发展中国家的项目。
Semin Thromb Hemost. 2005 Nov;31(5):555-60. doi: 10.1055/s-2005-922227.
8
Demographics of hemophilia in developing countries.发展中国家血友病的人口统计学情况。
Semin Thromb Hemost. 2005 Nov;31(5):489-94. doi: 10.1055/s-2005-922218.
9
Towards achieving global haemophilia care--World Federation of Hemophilia programmes.迈向全球血友病护理——世界血友病联盟计划
Haemophilia. 1998 Jul;4(4):463-73. doi: 10.1046/j.1365-2516.1998.440463.x.
10
WFH: back to the future.居家办公：回归未来。
Haemophilia. 2004 Oct;10 Suppl 4:1-8. doi: 10.1111/j.1365-2516.2004.00981.x.

引用本文的文献

1
Comparative Effectiveness of Valoctocogene Roxaparvovec and Efanesoctocog Alfa in the Treatment of Severe Hemophilia A: A Matching-Adjusted Indirect Comparison of Bleeding Frequency.Valoctocogene Roxaparvovec与Efanesoctocog Alfa治疗重度A型血友病的比较疗效：出血频率的匹配调整间接比较
Adv Ther. 2025 Sep 9. doi: 10.1007/s12325-025-03339-9.
2
The effects of traumatic pain memories on current pain experience in men with hemophilia.创伤性疼痛记忆对血友病男性患者当前疼痛体验的影响。
Can J Pain. 2025 Sep 4;9(1):2530966. doi: 10.1080/24740527.2025.2530966. eCollection 2025.
3
Turning up the heat: optimizing Bethesda assays for efanesoctocog alfa monitoring.
提高检测灵敏度：优化用于监测依艾托考格α的贝塞斯达检测法。
Res Pract Thromb Haemost. 2025 Aug 5;9(6):102992. doi: 10.1016/j.rpth.2025.102992. eCollection 2025 Aug.
4
Clinical Burden and Healthcare Resource Use Among Adults Living with Hemophilia A: An Observational Study.血友病A成年患者的临床负担与医疗资源利用：一项观察性研究
Drugs Real World Outcomes. 2025 Sep 1. doi: 10.1007/s40801-025-00516-8.
5
Advantages of FVIII-Extended Half-Life (Turoctocog Alfa Pegol) in the Management of Cardiac Surgery in a Patient with Mild Hemophilia A: A Case Report and Literature Review.八因子延长半衰期药物（聚乙二醇化重组人凝血因子VIII）在轻度甲型血友病患者心脏手术管理中的优势：病例报告及文献综述
Hematol Rep. 2025 Aug 6;17(4):41. doi: 10.3390/hematolrep17040041.
6
Cautious use of activated prothrombin complex concentrate in patients receiving emicizumab: new evidence and clinical considerations.在接受艾美赛珠单抗治疗的患者中谨慎使用活化凝血酶原复合物浓缩剂：新证据及临床考量
Res Pract Thromb Haemost. 2025 Jul 24;9(5):102983. doi: 10.1016/j.rpth.2025.102983. eCollection 2025 Jul.
7
Acute safety, cardiovascular, perceptual and neuromuscular responses to autoregulated and non-autoregulated blood flow restriction training during elbow rehabilitation in people with hemophilia.血友病患者肘部康复期间，对自动调节和非自动调节血流限制训练的急性安全性、心血管、感知及神经肌肉反应。
Front Sports Act Living. 2025 Jul 31;7:1587615. doi: 10.3389/fspor.2025.1587615. eCollection 2025.
8
TSUBASA study: evaluation of the quality and content of daily life of people with hemophilia A without factor VIII inhibitors on prophylactic treatment with emicizumab.TSUBASA研究：评估接受emicizumab预防性治疗的无因子VIII抑制剂的A型血友病患者的生活质量和日常生活内容。
Res Pract Thromb Haemost. 2025 Jul 16;9(5):102971. doi: 10.1016/j.rpth.2025.102971. eCollection 2025 Jul.
9
Analysis of the current situation and influencing factors of home treatment for children with hemophilia in China.中国血友病患儿家庭治疗的现状及影响因素分析
Ann Hematol. 2025 Aug 15. doi: 10.1007/s00277-025-06552-2.
10
Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice.接受依美珠单抗预防治疗的患者使用活化凝血酶原复合物浓缩剂：从证据到临床实践
Res Pract Thromb Haemost. 2025 Jun 17;9(4):102926. doi: 10.1016/j.rpth.2025.102926. eCollection 2025 May.